Evidence map›Paper›PMID 41070612›Full record

ReviewInternational journal of molecular medicine2025

Advances in RNA modification in myocardial fibrosis (Review).

Xiaowen Wu, Ruiquan Wang, Xinzhe Chen, Kun Wang

Abstract readReview
In one paragraph

Review in International journal of molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. mBiomolecules · 2026
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiaowen Wu *Key Laboratory of Maternal and Fetal Medicine of National Health Commission of China, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Shandong 250014, P.R. China.
Ruiquan Wang *Department of Cardiovascular Surgery, Institute of Chronic Diseases, The Affiliated Hospital of Qingdao University, School of Basic Medicine, College of Medicine, Qingdao University, Qingdao, Shandong 266021, P.R. China.
Xinzhe ChenDepartment of Cardiovascular Surgery, Institute of Chronic Diseases, The Affiliated Hospital of Qingdao University, School of Basic Medicine, College of Medicine, Qingdao University, Qingdao, Shandong 266021, P.R. China.
Kun WangKey Laboratory of Maternal and Fetal Medicine of National Health Commission of China, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Shandong 250014, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myocardial fibrosis has emerged as a maladaptive remodeling process characterized by dysregulated extracellular matrix (ECM) deposition following cardiac injury. Recent studies have unveiled a complex RNA epitranscriptomic network that is composed of nine major types of RNA modification, namely

Indexed as

CardiomyopathiesMyocardiumRNARNA Processing, Post-TranscriptionalAnimalsExtracellular MatrixFibrosisHumansMethyltransferasesSignal TransductionMethyltransferasesRNAacetylationcardiac fibrosiscardiovascular diseasemethylationRNA modification

Identifiers

PMID41070612
PMCPMC12530796

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.